Loading...
CalciMedica, Inc.
CALC•NASDAQ
Healthcare
Biotechnology
$2.00
$0.38(23.46%)
CalciMedica, Inc. (CALC) Financial Performance & Statements
Review CalciMedica, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-10.65%
↓ 10.65%
Net Income Growth
60.12%
↑ 60.12%
Operating Cash Flow Growth
17.82%
↑ 17.82%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-156.72%
↓ 156.72%
ROIC
-119.37%
↓ 119.37%
CalciMedica, Inc. (CALC) Financial Statements
Explore quarterly and annual reports for CalciMedica, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $15000.00 | $15000.00 |
| Gross Profit | $0.00 | $0.00 | -$15000.00 | -$15000.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $3.83M | $3.55M | $4.16M | $2.94M |
| SG&A Expenses | $2.34M | $2.19M | $2.37M | $2.82M |
| Operating Expenses | $6.17M | $5.74M | $6.53M | $5.77M |
| Total Costs & Expenses | $6.17M | $5.74M | $6.53M | $5.77M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $14000.00 | $15000.00 | $14000.00 | $15000.00 |
| EBITDA | -$6.16M | -$5.72M | -$6.53M | -$5.75M |
| EBITDA Ratio | ||||
| Operating Income | -$6.17M | -$5.74M | -$6.53M | -$5.77M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $1.91M | $118000.00 | $2.58M | $5.90M |
| Income Before Tax | -$4.26M | -$5.62M | -$3.95M | $130000.00 |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$15000.00 |
| Net Income | -$4.26M | -$5.62M | -$3.95M | $130000.00 |
| Net Income Ratio | ||||
| EPS | -$0.33 | -$0.50 | -$0.36 | $0.01 |
| Diluted EPS | -$0.33 | -$0.50 | -$0.36 | $0.01 |
| Weighted Avg Shares Outstanding | $12.76M | $11.13M | $11.13M | $9.75M |
| Weighted Avg Shares Outstanding (Diluted) | $12.76M | $11.13M | $11.13M | $10.05M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan